Vident Advisory’s Xenon Pharmaceuticals XENE Stock Holding History

Vident Advisory’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$221K	Buy
2024 Q4	$212K	Buy
2024 Q3	–	Sell
2024 Q2	$276K	Sell
2024 Q1	$336K	Buy
2023 Q4	$244K	Buy